Planned Parenthood of the Pacific Southwest has started offering an HIV prevention injection as part of its services, it was ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

The U.S. Supreme Court could make a decision Friday that would rattle Gilead Sciences' newest HIV prevention drug.

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

The world of HIV Prevention scored a major victory to end the year and it’s hard not to suspect that Santa Claus may have had a role in delivering this gift; well, maybe not Santa but the Food and ...

What kind of uptake can Gilead Sciences expect for its highly touted, long-acting HIV pre-exposure prophylaxis (PrEP) ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The US Food and Drug Administration (FDA) has approved a new shot to prevent HIV, offering a long-acting alternative to daily ...

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...

Gilead Sciences garnered investor and analyst focus after the U.S. FDA approval of Yeztugo, or lenacapavir, the company’s ...